4//SEC Filing
Shandell Jason B. 4
Accession 0001104659-20-012712
CIK 0001297184other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 8:08 PM ET
Size
19.6 KB
Accession
0001104659-20-012712
Insider Transaction Report
Form 4
Shandell Jason B.
DirectorPresident
Transactions
- Exercise/Conversion
Common Stock
2020-02-05$14.40/sh+15,615$224,856→ 154,513 total - Sale
Common Stock
2020-02-05$19.57/sh−15,615$305,554→ 138,898 total - Exercise/Conversion
Common Stock
2020-02-06$14.40/sh+21,933$315,835→ 160,831 total - Sale
Common Stock
2020-02-06$19.83/sh−21,933$434,951→ 138,898 total - Exercise/Conversion
Common Stock
2020-02-07$14.40/sh+6,853$98,683→ 145,751 total - Sale
Common Stock
2020-02-07$19.88/sh−6,853$136,260→ 138,898 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-02-06−21,933→ 53,797 totalExercise: $14.40Exp: 2024-03-27→ Common Stock (21,933 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-02-07−6,853→ 46,944 totalExercise: $14.40Exp: 2024-03-27→ Common Stock (6,853 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-02-05−15,615→ 75,730 totalExercise: $14.40Exp: 2024-03-27→ Common Stock (15,615 underlying)
Footnotes (5)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.35 to $19.77 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
- [F3]The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $19.58 to $19.99, inclusive.
- [F4]The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $19.83 to $20.00, inclusive.
- [F5]Shares subject to the option are fully vested and immediately exercisable.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001611148
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 8:08 PM ET
- Size
- 19.6 KB